Metronomic Cyclophosphamide and Methotrexate Chemotherapy Combined with 1E10 Anti-Idiotype Vaccine in Metastatic Breast Cancer
The use of low doses of cytotoxic agents continuously for prolonged periods is an alternative for the treatment of patients with metastatic breast cancer who have developed resistance to conventional chemotherapy. The combination of metronomic chemotherapy with therapeutic vaccines might increase th...
Saved in:
Main Authors: | Jorge L. Soriano, Noyde Batista, Eduardo Santiesteban, Mayté Lima, Joaquín González, Robin García, Yohanka Zarza, María V. López, Myriam Rodríguez, Jorge L. Loys, Narciso Montejo, Frank Aguirre, Amparo Macías, Ana M. Vázquez |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | International Journal of Breast Cancer |
Online Access: | http://dx.doi.org/10.4061/2011/710292 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Fountainpen and the Metronome: Bloomsbury Dancing, or not
by: Caroline Marie
Published: (2005-12-01) -
Anti-Idiotypic Antibody as a Booster Vaccine Against Respiratory Syncytial Virus
by: Shreya Mukhopadhyay, et al.
Published: (2025-01-01) -
Dynamics and control of a mathematical model for metronomic chemotherapy
by: Urszula Ledzewicz, et al.
Published: (2015-07-01) -
B-CD8+ T Cell Interactions in the Anti-Idiotypic Response against a Self-Antibody
by: Darel Martínez, et al.
Published: (2017-01-01) -
Cyclophosphamide: An Overview
by: Aditya Kumar Bubna
Published: (2025-01-01)